key: cord-0924451-ts17k7m1
authors: M. Dujon, Antoine; Brown, Joel S.; Destoumieux‐Garzón, Delphine; Vittecoq, Marion; Hamede, Rodrigo; Tasiemski, Aurélie; Boutry, Justine; Tissot, Sophie; Alix‐Panabieres, Catherine; Pujol, Pascal; Renaud, François; Simard, Frédéric; Roche, Benjamin; Ujvari, Beata; Thomas, Frédéric
title: On the need for integrating cancer into the One Health perspective
date: 2021-10-08
journal: Evol Appl
DOI: 10.1111/eva.13303
sha: 8708ee74a50c1ccd8898e200dfb40bf77c3b3bf1
doc_id: 924451
cord_uid: ts17k7m1

Recent pandemics have highlighted the urgency to connect disciplines studying animal, human, and environment health, that is, the “One Health” concept. The One Health approach takes a holistic view of health, but it has largely focused on zoonotic diseases while not addressing oncogenic processes. We argue that cancers should be an additional key focus in the One Health approach based on three factors that add to the well‐documented impact of humans on the natural environment and its implications on cancer emergence. First, human activities are oncogenic to other animals, exacerbating the dynamics of oncogenesis, causing immunosuppressive disorders in wildlife with effects on host–pathogen interactions, and eventually facilitating pathogen spillovers. Second, the emergence of transmissible cancers in animal species (including humans) has the potential to accelerate biodiversity loss across ecosystems and to become pandemic. It is crucial to understand why, how, and when transmissible cancers emerge and spread. Third, translating knowledge of tumor suppressor mechanisms found across the Animal Kingdom to human health offers novel insights into cancer prevention and treatment strategies.

The "One World-One Health" concept, initiated in 2004, recognizes the close connections between health of humans and that of other animals and our shared environment. The importance of this concept is evidenced by the accelerated emergence or re-emergence of zoonoses (e.g., Ebola, current COVID-19 pandemic) over the last decades (Peyre et al., 2021) . Although the One Health approach proposes a holistic view of health, it has, and still remains, largely focused on zoonotic and vector-borne diseases. Reasons behind this bias are multiple, ranging from the fact that historically it has originated from a collaboration between human and veterinary medicines, and also because zoonotic diseases undoubtedly represent major health and economic threats to human societies. The scope has broadened with the inclusion of other fields, such as antimicrobial resistance (WHO, 2015) , (eco)toxicology, and health in urban environments (Destoumieux-Garzón et al., 2018) , but not cancer.

The impact of human activities on the natural environment and their implications on cancer emergence in humans have been largely documented (e.g., anthropogenic pollution, occupation, food, and lifestyle; Aktipis & Nesse, 2013) (Briffa et al., 2020; Erren et al., 2015; Turner et al., 2020) . These effects and their consequences could increase in the context of climate change (Hiatt & Beyeler, 2020) . Beyond this acknowledged link between the environment and cancer, we discuss here three reasons for a broader inclusion of cancer into the One Health concept.

First, the interplay/interactions between cancer and infectious diseases make arduous to separate these communicable and noncommunicable diseases, and their combination could pose higher risk for human and animal health. For instance, cancers can cause immunosuppression 2020); cancers can also be induced by pathogens (Ewald & Swain Ewald, 2015; Jacqueline et al., 2017) . However, little attention has been paid to the role of human-induced cancers in infectious diseases' emergence and spread. Human activities elevate cancer incidences for wildlife species (via chemical pollution, changes in diet, and reductions in genetic diversity; Baines et al., 2021; Giraudeau et al., 2018; Sepp et al., 2019; Ujvari et al., 2018) . As in humans, cancer burdens generate a range of immunosuppressive disorders in livestock, and likely in wildlife (Pollock & Roth, 1989; Vittecoq et al., 2013) . Animals with cancer, human or otherwise, may be more susceptible, contagious, and debilitated by infectious diseases. Therefore, the evolutionary mismatch between enhanced human-induced cancer risks and maladapted cancer defense levels in animals will indirectly amplify pathogen dynamics in wildlife, in both natural and human-dominated ecosystems. In undisturbed natural environments, a fraction of pathogens is generally maintained by the presence of immunocompromised individuals, a stable equilibrium, that has been reached over evolutionary time (Hassell et al., 2021) .

This is an open access article under the terms of the Creat ive Commo ns Attri bution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. © 2021 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd anthropogenic activities can disrupt these equilibria. These altered dynamics are complex and not merely correlated with pollution levels, but also driven by, for example, the different susceptibilities of exposed species to carcinogenesis. For instance, a benthic lifestyle within fish communities contributes to elevated cancer incidence through chronic exposure to contaminated sediment and/or consumption of contaminated invertebrates (Black & Baumann, 1991; Martineau et al., 2002) . The consequences of these disturbances are difficult to predict given the cascade of indirect effects that may subsequently occur. For example, the impact of higher cancer incidences and carcinogens will depend on the species most affected by cancer (e.g., predators or prey species) and the resulting immunosuppressive disorders (see, for instance, Perret et al., 2020) . The relationship between an animal's immunosuppression and cancer burden (e.g., linear, exponential, negative binomial, and with or without critical thresholds) may also vary with species and/or with the organ in which malignancies develop. Clearly, the roles of pollutioninduced oncogenesis and immunosuppression in boosting pathogen communities in wildlife and their spread to humans are poorly understood at the moment. Given that parasitism and disease spread may also be limited in ecological communities via mechanisms such as the dilution effect (Civitello et al., 2015) , pollution-induced oncogenesis could amplify these transfers if it concomitantly promotes a decline in biodiversity.

A second reason for elevating the importance of cancers in the One Health approach concerns cancers that can themselves become transmissible. There are currently nine known transmissible cancer lineages (one in dogs, two in Tasmanian devil populations, and six in marine bivalves; Dujon, Gatenby, et al., 2020) , some of which threaten the survival of animal populations (and species) and are detrimental to ecosystem stability (see, for instance, Hamede et al., 2020) . Indubitably, this number is a gross underestimate due to poor monitoring of cancer in wildlife Dujon, Gatenby, et al., 2020; Ujvari et al., 2016) . The conditions for the emergence of transmissible cancers, while poorly understood, require a perfect storm of sequential steps that is reminiscent of a parasitic lifestyle. Environmental stress, lack of genetic diversity within the host population, and other infectious diseases may weaken the host's immune system enabling transmission and establishment of cancer cells from one individual to another Dujon, Gatenby, et al., 2020; . Human activities may also disperse certain transmissible cancers across the globe, giving previously isolated outbreaks pandemic potentials. Already, a single transmissible cancer lineage has been observed in multiple marine mussel species across multiple oceans, suggesting dispersal by aquaculture and/or shipping (Bramwell et al., 2021; Skazina et al., 2021; Yonemitsu et al., 2019) . A full understanding of the ecological impacts of transmissible cancers on ecosystems and biodiversity will require integrating tools from landscape ecology, conservation biology, and epidemiology to identify wildlife species at risk of contagious malignant cell lines, detect their emergence, anticipate their spread, and evaluate consequences to natural and humandominated ecosystems (Bramwell et al., 2021; Dujon, Gatenby, et al., 2020; . A worstcase scenario might involve the emergence of a communicable cancer in humans or in livestock, yielding environmental and human/ animal health crises similar to classical epidemics and epizootics.

Finally, a third reason to consider cancer in the One Health approach lies in the scientific insights provided by comparative oncology focusing on the diverse tumor suppression mechanisms that have evolved across the animal kingdom (Nunney et al., 2015; . Cancers appeared during the transition from unicellular to metazoan life, approximately one billion years ago (Domazet-Lošo & Tautz, 2010) . Cancers occur in all branches of multicellular life, and they have evolved diverse adaptations to prevent cancer initiation, suppress malignant progression, and alleviate negative fitness consequences of tumor burdens (Aktipis et al., 2015) . For instance, one might expect large/long-lived animals to have more cancers than smaller/shorter-lived ones, given that the former have many more cell divisions that potential give rise to cancer-initiating mutations, but such a relationship across species is not observed, due to the various mechanisms of cancer resistance that have evolved in large and long-lived species (i.e., Peto's Paradox, Tollis et al., 2017) .

Even in smaller species, under particular ecological conditions, selection can favor high levels of cancer resistance, as observed in naked-mole rats and bats (Lambert & Portfors, 2017; Seluanov et al., 2018; Tian et al., 2013) . Scientists are increasingly focusing on the ways natural selection has protected animal species from cancer (Boutry et al., 2020) . This work is deciphering the underlying tissue, cellular, and genomic mechanisms in cancer-resistant/tolerant species (Abegglen et al., 2015; Keane et al., 2015; Sulak et al., 2016) .

Another particularly interesting direction of comparative oncology investigates the local evolution of adaptations in species or populations that have been living in environments with excesses of naturally occurring carcinogens (Hourdez et al., 2021; Vittecoq et al., 2018) . To what extent do these populations show adaptations to prevent the emergence of cancer versus adaptations to mitigate the negative effects of cancer burdens? To what extent do these populations' anti-cancer adaptations increase or decrease susceptibility to infectious diseases? Of particular interest would be adaptations that simultaneously reduce cancer and infections. Studying species and ecological communities chronically exposed to carcinogens, with a particular focus on host-pathogen dynamics, could shed light on the possible impacts and repercussions of human-induced cancers within wildlife species . From a medical perspective, the adaptations of long-lived mammals and other species for preventing and suppressing cancer should inspire nature-based solutions to cancer, such as novel cancer treatment strategies, by mimicking the processes allowing these organisms to prevent or limit malignant progression despite high levels of mutagenic substances.

Thus, comparative oncology offers key insights into cancer epidemiology, prevention, and novel therapies for humans.

In conclusion, humans, domestic animals, and wildlife species are on the front lines of environmental changes and exposure to toxic hazards from anthropogenic activities. While it is well recognized that these processes directly affect immunity and hence pathogen dynamics (e.g., Dittmar et al., 2014; Tracy et al., 2020) , much less is known concerning the indirect links resulting from interactions involving non-communicable diseases, such as cancer. The direct and indirect effects do not necessarily yield the same outcomes. Cancercausing or cancer-associated processes are undoubtedly an underappreciated health consequence of modern anthropogenic changes, and they cannot be considered in isolation from other biological players in ecosystems, especially pathogens. Ecological impacts, sooner or later, are usually followed by evolutionary responses, leading to novel equilibria in ecosystems. However, we currently ignore how the novel equilibria will be achieved and shaped in an increasingly stressful world. A particular question remaining to be answered is how pollution and consequent oncogenic processes will impact infectious diseases and thus human health particularly before reaching a novel equilibrium. Exploring the interplay between human activities, novel cancer risks experienced by wildlife species, cancer defense evolution, biotic interactions, and infectious disease dynamics, notably those transmissible to humans, should become a stronger topic within the One Health perspective (Figure 1 ). Because one single method or model cannot thoroughly describe these complex dynamics, more than ever researchers must engage in greater exchanges and collaborations involving different disciplines, such as field and experimental ecology, epidemiology, eco-toxicology, immunology, evolutionary biology, oncology, and pharmacy.

Data sharing is not applicable to this article as no new data were created or analyzed in this study. Frédéric Thomas 1,2 F I G U R E 1 Cancer in the One Health perspective: comparative oncology, interplay between human activities, novel cancer risks experienced by wildlife species, and infectious disease dynamics 1

Potential mechanisms for cancer resistance in elephants and comparative cellular response to DNA damage in humans

Cancer across the tree of life: Cooperation and cheating in multicellularity

Evolutionary foundations for cancer biology

Linking pollution and cancer in aquatic environments: A review

Carcinogens and cancers in freshwater fishes

Ecological and evolutionary consequences of anticancer adaptations

A review of the potential effects of climate change on disseminated neoplasia with an emphasis on efficient detection in marine bivalve populations

Heavy metal pollution in the environment and their toxicological effects on humans. Heliyon, 6, e04691

Biodiversity inhibits parasites: Broad evidence for the dilution effect

The one health concept: 10 Years old and a long road ahead

Heat and immunity: An experimental heat wave alters immune functions in three-spined sticklebacks (Gasterosteus aculeatus)

Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa

Transmissible cancers in mammals and bivalves: How many examples are there?

Transmissible cancers in an evolutionary perspective

Cancer risk landscapes: A framework to study cancer in ecosystems

Plastic ocean": What about cancer? Environmental Pollution

Infection and cancer in multicellular organisms

Human activities might influence oncogenic processes in wild animal populations

The ecology and evolution of wildlife cancers: Applications for management and conservation

Towards an ecosystem model of infectious disease

Cancer and climate change

Investigation of Capitella spp. symbionts in the context of varying anthropic pressures: First occurrence of a transient advantageous epibiosis with the giant bacteria Thiomargarita sp. to survive seasonal increases of sulfides in sediments

Infections and cancer: The "fifty shades of immunity" hypothesis

Immune suppression in pregnancy and cancer: Parallels and insights

Insights into the evolution of longevity from the bowhead whale genome

Adaptive sequence convergence of the tumor suppressor ADAMTS9 between small-bodied mammals displaying exceptional longevity

Cancer in wildlife, a case study: Beluga from the St. Lawrence estuary

Peto's paradox and the promise of comparative oncology

Predation shapes the impact of cancer on population dynamics and the evolution of cancer resistance

PREZODE: Preventing zoonotic disease emergence. The Lancet

Cancer-induced immunosuppression: Implications for therapy?

Comparative oncology: What dogs and other species can teach us about humans with cancer

Mechanisms of cancer resistance in long-lived mammals

Urban environment and cancer in wildlife: Available evidence and future research avenues

First description of a widespread Mytilus trossulus-derived bivalve transmissible cancer lineage in M. trossulus itself

TP53 copy number expansion is associated with the evolution of increased body size and an enhanced DNA damage response in elephants. elife, 5, e11994

High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat

Peto's Paradox: How has evolution solved the problem of cancer prevention

Warming and pollutants interact to modulate octocoral immunity and shape disease outcomes

Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations

Transmissible cancers, are they more common than thought?

Transmissible cancer: The evolution of interindividual metastasis

Genetic diversity, inbreeding and cancer

Turning natural adaptations to oncogenic factors into an ally in the war against cancer

Cancer: A missing link in ecosystem functioning?

Global action plan on antimicrobial resistance

A single clonal lineage of transmissible cancer identified in two marine mussel species in South America and Europe. eLife

On the need for integrating cancer into the One Health perspective